Edition:
United Kingdom

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

2.14USD
13 Sep 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.14
Open
$2.16
Day's High
$2.17
Day's Low
$2.10
Volume
141,707
Avg. Vol
336,736
52-wk High
$2.94
52-wk Low
$0.52

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 3 0.00 0.00 0.00 --
Quarter Ending Mar-19 2 0.00 0.00 0.00 --
Year Ending Mar-19 3 0.00 0.00 0.00 --
Year Ending Mar-20 5 0.00 0.00 0.00 1.28
Year Ending Mar-21 5 3.94 15.85 0.00 3.96
Earnings (per share)
Quarter Ending Dec-19 4 -0.09 -0.08 -0.10 --
Quarter Ending Mar-19 2 -0.08 -0.05 -0.11 --
Year Ending Mar-19 2 -0.69 -0.54 -0.84 --
Year Ending Mar-20 5 -0.34 -0.15 -0.42 -0.40
Year Ending Mar-21 4 -0.24 -0.05 -0.45 -0.26
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 29.88 32.66
P/E High - Last 5 Yrs. -- 42.97 47.31
P/E Low - Last 5 Yrs. -- 23.37 23.88
Beta -- 0.89 0.89
Price to Sales (TTM) -- 6.26 7.91
Price to Book (MRQ) -- 5.26 5.38
Price to Tangible Book (MRQ) -- 5.93 6.71
Price to Cash Flow (TTM) -- 23.51 24.36
% Owned Institutions -- 0.75 1.45

Dividends

  Company industry sector
Dividend Yield -- 1.42 1.35
Dividend Yield - 5 Year Avg -- 1.44 1.38
Dividend 5 Year Growth Rate -- 3.90 4.54
Payout Ratio(TTM) -- 42.60 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 5.12 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 6.49 7.74
Sales - 5 Yr. Growth Rate -- 10.59 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 40.58 42.97
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.78 10.31
Capital Spending - 5 Yr. Growth Rate -- 15.44 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.21
Current Ratio (MRQ) -- 2.93 3.03
LT Debt to Equity (MRQ) -- 7.94 10.20
Total Debt to Equity (MRQ) -- 11.63 14.55
Interest Coverage (TTM) -- 33.56 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.86 52.24
Gross Margin - 5 Yr. Avg. -- 49.68 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 17.36 13.12
Operating Margin (TTM) -- 13.68 6.81
Operating Margin - 5 Yr. Avg. -- 13.91 8.92
Pre-Tax Margin (TTM) -- 12.30 5.99
Pre-Tax Margin - 5 Yr. Avg. -- 14.32 9.22
Net Profit Margin (TTM) -- 9.08 2.63
Net Profit Margin - 5 Yr. Avg. -- 10.75 5.58
Effective Tax Rate (TTM) -- 22.44 22.40
Effective Tax Rate - 5 Yr. Avg. -- 22.49 22.75

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 992,970,993 887,293,452
Net Income/Employee (TTM) -- 114,017,316 101,845,288
Receivable Turnover (TTM) -- 5.96 5.93
Inventory Turnover (TTM) -- 2.62 3.36
Asset Turnover (TTM) -- 0.97 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.51 11.17
Return on Assets - 5 Yr. Avg. -- 12.96 12.34
Return on Investment (TTM) -- 14.89 14.48
Return on Investment - 5 Yr. Avg. -- 16.86 16.02
Return on Equity (TTM) -- 16.01 15.78
Return on Equity - 5 Yr. Avg. -- 17.66 17.01
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.